Therapeutic developments: Masters of medicine

RT @NatureOutlook: Women in science and engineering are joining the entrepreneurial ranks. @womensday https://t.co/EVb2xNJG8e https://t.co…

Women in science and engineering are joining the entrepreneurial ranks. @womensday https://t.co/EVb2xNJG8e https://t.co/HS7LUJarvn

Therapeutic developments: Masters of medicine. https://t.co/VPhyHkfCEd #microbiome https://t.co/o6v56hOt99

Clinical testing gets a new skin: https://t.co/zrgz9zCAre via @nature https://t.co/aHPsOc61R7

https://t.co/PD8TIsIvZO

Clinical testing gets a new skin: https://t.co/zrgz9zCAre via @nature https://t.co/mpGF771P2O

Clinical testing gets a new skin. https://t.co/WkyW1ZU0rr @NTUsg https://t.co/yjOPDL4KZX

How university spinoff Sapience went from crossed finger to millions in financing. https://t.co/SD1DT1iDrI @Columbia, @Columbia_Tech https://t.co/OIEcnaV7gl

RT @keitoxford: #StartedinOxford @OxfordChemistry & @DPAGAthenaSwan https://t.co/z2JyYuxFiY

#StartedinOxford @OxfordChemistry & @DPAGAthenaSwan https://t.co/z2JyYuxFiY

RT @NatureOutlook: Can stem cells regulated by small molecules treat age-related disease? @OxStem @UniofOxford @keitoxford https://t.co/Ry5…

RT @NatureOutlook: Can stem cells regulated by small molecules treat age-related disease? @OxStem @UniofOxford @keitoxford https://t.co/Ry5…

Can stem cells regulated by small molecules treat age-related disease? @OxStem @UniofOxford @keitoxford https://t.co/Ry5H2OyL3i https://t.co/amT11rtHdv

RT @NatureOutlook: Building a 3D printer for living tissue was the easy part for @TUBerlin spinoff Cellbricks. Finding $ was tougher. http…

Building a 3D printer for living tissue was the easy part for @TUBerlin spinoff Cellbricks. Finding $ was tougher. https://t.co/YJq4JgKOua https://t.co/3n15sv4yJp

@Stanford spinoff Antheia is creating a synthetic biology pathway to producing opioids. https://t.co/5sacOfyZCu https://t.co/uzVR3OKDh8

RT @NatureOutlook: Meet the @MIT startup rewiring bacteria to act as living therapeutics https://t.co/OIu7f0pAOi https://t.co/giuIYMOjC2

Meet the @MIT startup rewiring bacteria to act as living therapeutics https://t.co/OIu7f0pAOi https://t.co/giuIYMOjC2

RT @nature: Masters of medicine: Read now 6 university spinoff companies are developing better therapies https://t.co/6I7vM1F2wz @NatureOut…

RT @nature: Masters of medicine: Read now 6 university spinoff companies are developing better therapies https://t.co/6I7vM1F2wz @NatureOut…

RT @nature: Masters of medicine: Read now 6 university spinoff companies are developing better therapies https://t.co/6I7vM1F2wz @NatureOut…

RT @nature: Masters of medicine: Read now 6 university spinoff companies are developing better therapies https://t.co/6I7vM1F2wz @NatureOut…

RT @nature: Masters of medicine: Read now 6 university spinoff companies are developing better therapies https://t.co/6I7vM1F2wz @NatureOut…

RT @nature: Masters of medicine: Read now 6 university spinoff companies are developing better therapies https://t.co/6I7vM1F2wz @NatureOut…

RT @nature: Masters of medicine: Read now 6 university spinoff companies are developing better therapies https://t.co/6I7vM1F2wz @NatureOut…

RT @nature: Masters of medicine: Read now 6 university spinoff companies are developing better therapies https://t.co/6I7vM1F2wz @NatureOut…

RT @nature: Masters of medicine: Read now 6 university spinoff companies are developing better therapies https://t.co/6I7vM1F2wz @NatureOut…

RT @nature: Masters of medicine: Read now 6 university spinoff companies are developing better therapies https://t.co/6I7vM1F2wz @NatureOut…

RT @nature: Masters of medicine: Read now 6 university spinoff companies are developing better therapies https://t.co/6I7vM1F2wz @NatureOut…

RT @nature: Masters of medicine: Read now 6 university spinoff companies are developing better therapies https://t.co/6I7vM1F2wz @NatureOut…

RT @nature: Masters of medicine: Read now 6 university spinoff companies are developing better therapies https://t.co/6I7vM1F2wz @NatureOut…

RT @nature: Masters of medicine: Read now 6 university spinoff companies are developing better therapies https://t.co/6I7vM1F2wz @NatureOut…

RT @nature: Masters of medicine: Read now 6 university spinoff companies are developing better therapies https://t.co/6I7vM1F2wz @NatureOut…

Therapeutic developments: Masters of medicine https://t.co/oO4fiY5O8c

RT @nature: Masters of medicine: Read now 6 university spinoff companies are developing better therapies https://t.co/6I7vM1F2wz @NatureOut…

RT @nature: Masters of medicine: Read now 6 university spinoff companies are developing better therapies https://t.co/6I7vM1F2wz @NatureOut…

RT @nature: Masters of medicine: Read now 6 university spinoff companies are developing better therapies https://t.co/6I7vM1F2wz @NatureOut…

RT @nature: Masters of medicine: Read now 6 university spinoff companies are developing better therapies https://t.co/6I7vM1F2wz @NatureOut…

RT @nature: Masters of medicine: Read now 6 university spinoff companies are developing better therapies https://t.co/6I7vM1F2wz @NatureOut…

RT @nature: Masters of medicine: Read now 6 university spinoff companies are developing better therapies https://t.co/6I7vM1F2wz @NatureOut…

Masters of medicine: Read now 6 university spinoff companies are developing better therapies https://t.co/6I7vM1F2wz @NatureOutlook https://t.co/RfIn4SpxQK

RT @NatureOutlook: Meet the university spin-outs looking to change the face of medicine https://t.co/EVb2xNs4JE https://t.co/hnM3hHolMf

RT @NatureOutlook: Not even 2 yrs old, Sapience Therapeutics is a @Columbia_tech spin-out with brain cancer in its sights https://t.co/SD1…

RT @NatureOutlook: Meet the university spin-outs looking to change the face of medicine https://t.co/EVb2xNs4JE https://t.co/hnM3hHolMf

Meet the university spin-outs looking to change the face of medicine https://t.co/EVb2xNs4JE https://t.co/hnM3hHolMf

RT @NatureOutlook: Not even 2 yrs old, Sapience Therapeutics is a @Columbia_tech spin-out with brain cancer in its sights https://t.co/SD1…

RT @NatureOutlook: Not even 2 yrs old, Sapience Therapeutics is a @Columbia_tech spin-out with brain cancer in its sights https://t.co/SD1…

Not even 2 yrs old, Sapience Therapeutics is a @Columbia_tech spin-out with brain cancer in its sights https://t.co/SD1DT1iDrI https://t.co/Z6GWOgfabc

RT @NatureOutlook: This @UniofOxford startup, working on small-molecule drugs that target stem cells, has an unusual company structure http…

RT @NatureOutlook: This startup from @NTUsg is offering drug and cosmetics makers an alternative to animal testing https://t.co/WkyW1ZCpzT…

Therapeutic developments: Masters of medicine https://t.co/d0GpoyB7wG

RT @NatureOutlook: Meet @OxStem, the @UniofOxford spinoff developing stem cell treatments for age-related diseases. https://t.co/Ry5H2OhabK…

RT @keitoxford: #StartedinOxford @OxfordChemistry & @DPAGAthenaSwan https://t.co/D6AuK1PGE3

RT @NatureOutlook: This startup from @NTUsg is offering drug and cosmetics makers an alternative to animal testing https://t.co/WkyW1ZCpzT…

RT @NatureOutlook: Meet @OxStem, the @UniofOxford spinoff developing stem cell treatments for age-related diseases. https://t.co/Ry5H2OhabK…

RT @NatureOutlook: This startup from @NTUsg is offering drug and cosmetics makers an alternative to animal testing https://t.co/WkyW1ZCpzT…

What an excellent idea! #tissueengineering #Cosmetic #AnimalCruelty https://t.co/vLfSzC3OBK

This startup from @NTUsg is offering drug and cosmetics makers an alternative to animal testing https://t.co/WkyW1ZCpzT https://t.co/P1UOsz7URb

RT @keitoxford: #StartedinOxford @OxfordChemistry & @DPAGAthenaSwan https://t.co/D6AuK1PGE3

RT @NatureOutlook: Meet @OxStem, the @UniofOxford spinoff developing stem cell treatments for age-related diseases. https://t.co/Ry5H2OhabK…

RT @NatureOutlook: Meet @OxStem, the @UniofOxford spinoff developing stem cell treatments for age-related diseases. https://t.co/Ry5H2OhabK…

RT @keitoxford: #StartedinOxford @OxfordChemistry & @DPAGAthenaSwan https://t.co/D6AuK1PGE3

#StartedinOxford @OxfordChemistry & @DPAGAthenaSwan https://t.co/D6AuK1PGE3

RT @NatureOutlook: Meet @OxStem, the @UniofOxford spinoff developing stem cell treatments for age-related diseases. https://t.co/Ry5H2OhabK…

RT @NatureOutlook: Meet @OxStem, the @UniofOxford spinoff developing stem cell treatments for age-related diseases. https://t.co/Ry5H2OhabK…

Meet @OxStem, the @UniofOxford spinoff developing stem cell treatments for age-related diseases. https://t.co/Ry5H2OhabK. , @keitoxford https://t.co/xhJREB5pmy

@stanford spinoff Antheia is enginering opioids from yeast. Could antibiotics and cancer drugs be next? https://t.co/5sacOfQAu2 https://t.co/Zf0qMN88d2

Meet @MIT spin-out Synlogic, which rewires bacteria to sense & regulate molecular pathways as "living therapeutics" https://t.co/OIu7f07ZpI https://t.co/FN99dU9Lgl

RT @NatureOutlook: Meet @MIT spin-out Synlogic, which rewires bacteria to sense & regulate molecular pathways as "living therapeutics" http…

Meet @MIT spin-out Synlogic, which rewires bacteria to sense & regulate molecular pathways as "living therapeutics" https://t.co/OIu7f07ZpI https://t.co/vvczkbXDvT

Therapeutic developments: Masters of medicine https://t.co/WzDbZyHpiU #startup #science #3D #therapeutic

RT @NatureOutlook: If this startup's drug candidate makes it to the clinic, it could be huge for people with hard-to-treat brain cancer htt…

If this startup's drug candidate makes it to the clinic, it could be huge for people with hard-to-treat brain cancer https://t.co/SD1DT1iDrI https://t.co/b01S8H2LQ1

RT @NatureOutlook: 3D printing living tissue is no problem for @TUBerlin spin-off Cellbricks. The difficult bit is finding the funding http…

RT @NatureOutlook: This @UniofOxford startup, working on small-molecule drugs that target stem cells, has an unusual company structure http…

RT @NatureOutlook: This @UniofOxford startup, working on small-molecule drugs that target stem cells, has an unusual company structure http…

RT @NatureOutlook: This @UniofOxford startup, working on small-molecule drugs that target stem cells, has an unusual company structure http…

RT @OxChemRF: Nice highlight of @OxfordChemistry's spinout @OxStem. #StartedinOxford https://t.co/PabKyjiDZ4

RT @OxChemRF: Nice highlight of @OxfordChemistry's spinout @OxStem. #StartedinOxford https://t.co/PabKyjiDZ4

RT @OxChemRF: Nice highlight of @OxfordChemistry's spinout @OxStem. #StartedinOxford https://t.co/PabKyjiDZ4

RT @OxChemRF: Nice highlight of @OxfordChemistry's spinout @OxStem. #StartedinOxford https://t.co/PabKyjiDZ4

Nice highlight of @OxfordChemistry's spinout @OxStem. #StartedinOxford https://t.co/PabKyjiDZ4

OxStem selected as 1 of 6 innovative & disruptive Biotech start-ups from around the world profiled in Nature article https://t.co/WrqRtaWC1a

.@OxStem #StartedinOxford @OxfordChemistry and @DPAGAthenaSwan https://t.co/u7GAPeB19m

RT @NatureOutlook: This @UniofOxford startup, working on small-molecule drugs that target stem cells, has an unusual company structure http…

This @UniofOxford startup, working on small-molecule drugs that target stem cells, has an unusual company structure https://t.co/Ry5H2OhabK https://t.co/8wbJUyN1ew

RT @NatureOutlook: 3D printing living tissue is no problem for @TUBerlin spin-off Cellbricks. The difficult bit is finding the funding http…

RT @NatureOutlook: 3D printing living tissue is no problem for @TUBerlin spin-off Cellbricks. The difficult bit is finding the funding http…

3D printing living tissue is no problem for @TUBerlin spin-off Cellbricks. The difficult bit is finding the funding https://t.co/YJq4JgKOua https://t.co/k6De2JaP07

RT @NatureOutlook: A young @NTUsg spin-off is providing the makers of cosmetics and drugs with an alternative to animal testing https://t.c…

A young @NTUsg spin-off is providing the makers of cosmetics and drugs with an alternative to animal testing https://t.co/WkyW1ZCpzT https://t.co/JAf5mWMpKE

Therapeutic developments: Masters of medicine via @nature #medicine #research https://t.co/EdJLqlbTEZ https://t.co/ZeGn4sDUIs

Más y más deberían animarse a esto, especialmente en Argentina https://t.co/NLbkRgA9xb

RT @NatureOutlook: Masters of medicine: how 6 university spinoff companies are developing better therapies. https://t.co/EVb2xNJG8e https:/…

RT @NatureOutlook: Masters of medicine: how 6 university spinoff companies are developing better therapies. https://t.co/EVb2xNJG8e https:/…

Masters of medicine: how 6 university spinoff companies are developing better therapies. https://t.co/EVb2xNJG8e https://t.co/HVyZSc0NG1

@Stanford spinoff Antheia is developing a less-expensive, and perhaps less-addictive, supply of opioids. https://t.co/5sacOfQAu2 https://t.co/W3bQ2eyuGe

New tissue engineered skin models for cosmetic, pharma testing from DeNova Sciences, @NTUsg spinout – via @Nature https://t.co/dRiE7YQ8mU https://t.co/kFSLHTqhat

Why make making opioids easier? Katie Bourzac '04 https://t.co/4ucnyNiveV

Therapeutic developments: Masters of medicine https://t.co/kry9Oj2qhC